ES2722973T3 - Obtención de imágenes en enfermedades neurológicas - Google Patents

Obtención de imágenes en enfermedades neurológicas Download PDF

Info

Publication number
ES2722973T3
ES2722973T3 ES14742544T ES14742544T ES2722973T3 ES 2722973 T3 ES2722973 T3 ES 2722973T3 ES 14742544 T ES14742544 T ES 14742544T ES 14742544 T ES14742544 T ES 14742544T ES 2722973 T3 ES2722973 T3 ES 2722973T3
Authority
ES
Spain
Prior art keywords
iii
relationship
subject
stage
neurological diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14742544T
Other languages
English (en)
Spanish (es)
Inventor
Mark Joseph Rosser
Jan Wolber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare Ltd
Original Assignee
GE Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare Ltd filed Critical GE Healthcare Ltd
Application granted granted Critical
Publication of ES2722973T3 publication Critical patent/ES2722973T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/48Diagnostic techniques
    • A61B6/481Diagnostic techniques involving the use of contrast agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/50Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
    • A61B6/501Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of the head, e.g. neuroimaging or craniography
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/52Devices using data or image processing specially adapted for radiation diagnosis
    • A61B6/5211Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data
    • A61B6/5217Devices using data or image processing specially adapted for radiation diagnosis involving processing of medical diagnostic data extracting a diagnostic or physiological parameter from medical diagnostic data
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/041Heterocyclic compounds
    • A61K51/044Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Neurosurgery (AREA)
  • Dentistry (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nuclear Medicine (AREA)
  • Pulmonology (AREA)
  • Theoretical Computer Science (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Primary Health Care (AREA)
ES14742544T 2013-07-25 2014-07-25 Obtención de imágenes en enfermedades neurológicas Active ES2722973T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1313291.5A GB201313291D0 (en) 2013-07-25 2013-07-25 Imaging neurological disease
PCT/EP2014/066042 WO2015011267A1 (en) 2013-07-25 2014-07-25 Imaging neurological disease

Publications (1)

Publication Number Publication Date
ES2722973T3 true ES2722973T3 (es) 2019-08-20

Family

ID=49166921

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14742544T Active ES2722973T3 (es) 2013-07-25 2014-07-25 Obtención de imágenes en enfermedades neurológicas

Country Status (16)

Country Link
US (1) US11051777B2 (enExample)
EP (1) EP3024501B1 (enExample)
JP (1) JP6590801B2 (enExample)
KR (1) KR102340504B1 (enExample)
CN (1) CN105392500B (enExample)
AU (2) AU2014294983B2 (enExample)
BR (1) BR112016001316B1 (enExample)
CA (1) CA2916125A1 (enExample)
DK (1) DK3024501T3 (enExample)
ES (1) ES2722973T3 (enExample)
GB (1) GB201313291D0 (enExample)
IL (1) IL243383B (enExample)
MX (1) MX2016001012A (enExample)
RU (1) RU2015155792A (enExample)
SG (1) SG11201600571RA (enExample)
WO (1) WO2015011267A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104720840A (zh) * 2015-02-11 2015-06-24 清华大学深圳研究生院 基于多巴胺转运体显像特异性摄取比的半自动量化方法
TWI587841B (zh) * 2015-03-06 2017-06-21 國立陽明大學 定量分析核子醫學腦部影像的系統及方法
US20180000440A1 (en) * 2015-03-24 2018-01-04 Nihon Medi-Physics Co., Ltd. Image processing apparatus, image processing method, and program
KR101720288B1 (ko) 2016-05-11 2017-03-28 (주)바이오액츠 뇌 영상용 염료 및 이의 제조방법
JP6549521B2 (ja) * 2016-05-25 2019-07-24 富士フイルム富山化学株式会社 疾患鑑別支援装置及びコンピュータプログラム
TWI607739B (zh) * 2016-05-27 2017-12-11 許百靈 Spect多巴胺顯像定量分析技術與在腦多巴胺評估的用途
GB201621698D0 (en) * 2016-12-20 2017-02-01 Ge Healthcare Ltd (Ip) And Stichting Vumc And Acad Medical Center Differential Diagnosis
JP6995642B2 (ja) * 2018-01-19 2022-01-14 日本メジフィジックス株式会社 画像処理装置、画像処理方法およびプログラム
TWI686178B (zh) * 2019-10-09 2020-03-01 中原大學 自動化定位核子醫學腦部影像紋狀體與計算紋狀體專一性攝取率的方法與系統
US20230001026A1 (en) * 2019-11-21 2023-01-05 Likeminds, Inc. Pharmaceutical packaging units and methods for concomitant administration of radiotracers
AR125188A1 (es) 2021-03-22 2023-06-21 Neurocrine Biosciences Inc Inhibidores del vmat2 y métodos de uso
CN119599879B (zh) * 2024-11-06 2025-10-24 复旦大学附属华山医院 一种基于深度学习的pet图像跨膜态合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009040727A2 (en) * 2007-09-26 2009-04-02 Philips Intellectual Property & Standards Gmbh Method of differentially diagnosing different types of dementia
US8084018B2 (en) * 2007-10-31 2011-12-27 Alseres Pharmaceuticals, Inc. Methods for imaging dopamine transporter level
US20100312105A1 (en) * 2007-10-31 2010-12-09 Alseres Pharmaceuticals, Inc. Methods for diagnosing and monitoring treatment of lewy body dementia by assessing dopamine transporter level

Also Published As

Publication number Publication date
CN105392500B (zh) 2023-08-18
WO2015011267A1 (en) 2015-01-29
IL243383B (en) 2018-07-31
RU2015155792A3 (enExample) 2018-05-23
CA2916125A1 (en) 2015-01-29
US11051777B2 (en) 2021-07-06
GB201313291D0 (en) 2013-09-11
AU2014294983A1 (en) 2016-01-21
RU2015155792A (ru) 2017-08-30
JP6590801B2 (ja) 2019-10-16
HK1222118A1 (zh) 2017-06-23
KR102340504B1 (ko) 2021-12-20
EP3024501A1 (en) 2016-06-01
KR20160037168A (ko) 2016-04-05
EP3024501B1 (en) 2019-03-27
DK3024501T3 (da) 2019-05-06
BR112016001316B1 (pt) 2021-04-06
US20160183897A1 (en) 2016-06-30
SG11201600571RA (en) 2016-02-26
JP2016531903A (ja) 2016-10-13
AU2014294983B2 (en) 2019-10-24
AU2019253837A1 (en) 2019-11-14
AU2019253837B2 (en) 2021-11-25
CN105392500A (zh) 2016-03-09
MX2016001012A (es) 2016-05-09

Similar Documents

Publication Publication Date Title
ES2722973T3 (es) Obtención de imágenes en enfermedades neurológicas
MX2019003148A (es) Base de datos, de datos moleculares, omicos, de inmunoterapia, metabolicos, epigeneticos y clinicos, integrados.
MX2018003764A (es) Metodo y aparato de prediccion de imagen.
MX2019000425A (es) Terapia anti-angiogenesis para el tratamiento del cancer ovarico.
MX2015012585A (es) Dilatación regulada por flujo para determinar la edad vascular.
EP3825419A3 (en) Diagnostic, prognostic and therapeutic uses of long noncoding rnas for heart disease and regenerative medicine
BR112015016023A2 (pt) método e aparelho de recomendação de modo de cenário para dispositivo inteligente
UY35548A (es) Péptidos terapéuticos para el tratamiento de trastornos metabólicos.
Pantic Social networking and depression: an emerging issue in behavioral physiology and psychiatric research.
CO2017000346A2 (es) Anticuerpos de unión a protofibrillas aβ
BR112014027594A2 (pt) dispositivo para apoiar uma mudança de comportamento de uma pessoa, método para apoiar uma mudança de comportamento de uma pessoa utilizando um dispositivo e programa de computador
BR112012028452A2 (pt) dispositivos e métodos para avaliar mudanças na saúde da córnea
BR112016006556A2 (pt) arranjos detectáveis, sistemas para diagnóstico, e métodos para produzir e usar os mesmos
EA201591742A1 (ru) Способ улучшения диагностики заболеваний с использованием измеряемых аналитов
BR112015024040A2 (pt) preparação alergênica
WO2015075240A3 (en) Method for in vitro diagnosing and prognosing of triple negative breast cancer recurrence
BR112016014071A2 (pt) Método de caracterização de uma peça
CR20140473A (es) Compuestos de pirazol como inhibidores de sglt1
EA201690537A1 (ru) Способы и средства для введения контрастной среды
BR112014009223A2 (pt) método para o diagnóstico da doença de niemann-pick
CL2015003563A1 (es) Marcador para trastornos de la esfingomielinasa ácida y sus usos.
BR112013031431A2 (pt) método para o diagnóstico da doença de gaucher
AR092423A1 (es) Metodo de diagnostico y tratamiento del cancer dirigido a las moleculas expresadas en celulas madre cancerosas
BR112015027249A2 (pt) método de diagnóstico de câncer
BR112017027304A2 (pt) método para o diagnóstico de doença de farber